Max Healthcare Institute Limited (NSE:MAXHEALTH)

Max Healthcare Institute Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	91,458	83,735	70,285	54,060	45,626	39,366
Revenue Growth	15.17%	19.14%	30.01%	18.49%	15.90%	56.96%
Gross Profit Gross Profit Growth	57,690	52,263	43,774	33,531	28,312	21,885
Operating Income Operating Income Growth	19,538	17,990	15,275	12,753	10,240	7,580
Net Income Net Income Growth	13,806	14,424	10,759	10,576	11,035	6,051
Earnings Per Share EPS Growth	14.13	14.76	11.01	10.84	11.36	6.24
EPS Growth	1.81%	34.06%	1.57%	-4.58%	82.05%	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	5,710	6,658	6,616	9,798	13,743	4,810
Total Debt Total Debt Growth	37,950	34,784	30,103	12,990	6,890	9,134
Net Cash (Debt) Net Cash Growth	-32,241	-28,126	-23,487	-3,191	6,854	-4,324
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-32.99	-28.78	-24.03	-3.27	7.05	-4.46

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	18,307	16,333	14,380	11,217	12,841	7,405
Capital Expenditures CapEx Growth	-12,349	-14,845	-9,445	-7,860	-3,356	-5,533
Free Cash Flow Free Cash Flow Growth	5,958	1,488	4,935	3,357	9,485	1,872
Free Cash Flow Growth	181.10%	-69.85%	46.99%	-64.61%	406.74%	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	63.08%	62.41%	62.28%	62.02%	62.05%	55.59%
Operating Margin	21.36%	21.48%	21.73%	23.59%	22.44%	19.25%
Pretax Margin	19.75%	20.01%	20.01%	25.26%	23.31%	18.77%
Profit Margin	15.10%	17.23%	15.31%	19.56%	24.19%	15.37%
FCF Margin	6.51%	1.78%	7.02%	6.21%	20.79%	4.75%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	2.000	2.000	1.500	1.500	1.000
Dividend Per Share Growth	33.33%	33.33%	0%	50.00%	-
Dividend Yield	0.22%	0.21%	0.14%	0.18%	0.23%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	65.62	64.88	99.10	75.39	38.80	55.59
P/FCF Ratio	151.27	628.95	216.05	237.51	45.14	179.70
PS Ratio	9.85	11.18	15.17	14.75	9.38	8.55

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error